country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-190477

Copy Link Print Information

WC-27

WC-27 is a selective Wee1 inhibitor with an IC₅₀ of 2.11 nM. WC-27 blocks Wee1-mediated inhibitory phosphorylation of CDK1 and disrupts the G2/M checkpoint. WC-27 induces S-phase cell cycle arrest and apoptosis, and inhibits cell migration and colony formation. WC-27 can be used for research on non-small cell lung cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 3069940-08-2
화학식: C₂₂H₂₅Cl₂N₇O₂
분자량:490.39

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

WC-27 Chemical Structure

CAS No.: 3069940-08-2

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- Parmacokinetics
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

IC₅₀ & Target

^[1]

WEE1

2.11 nM (IC₅₀)

CDK1

All Wee1 Isoforms :

PKMYT1

All CDK Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
NCI-H1299	IC50	1.05 μM	Antiproliferative activity against human NCI-H1299 non-small cell lung cancer cells assessed as viability reduction incubated 72 hrs by MTT assay. Antiproliferative activity against human NCI-H1299 non-small cell lung cancer cells assessed as viability reduction incubated 72 hrs by MTT assay.	42887067
LoVo	IC50	0.38 μM	Antiproliferative activity against human LOVO cells assessed as viability reduction incubated 72 hrs by MTT assay. Antiproliferative activity against human LOVO cells assessed as viability reduction incubated 72 hrs by MTT assay.	42887067
HCC1569	IC50	0.79 μM	Antiproliferative activity against human HCC1569 cells assessed as viability reduction incubated 72 hrs by MTT assay. Antiproliferative activity against human HCC1569 cells assessed as viability reduction incubated 72 hrs by MTT assay.	42887067

In Vitro

Anti-cancerCell Cycle Regulation

Anti-cancer

WC-27 (72 h) inhibits NCI-H1299 cell proliferation with an IC₅₀ of 1.05 µM^[1].
WC-27 (72 h) inhibits LOVO and HCC1569 cell proliferation with IC₅₀ values of 0.38 µM and 0.79 µM, respectively^[1].
WC-27 (2.5 μM) inhibits phosphorylation of CDK1 at Tyr15 in NCI-H1299 cells^[1].
WC-27 (0.625-5.0 μM; 24 h) inhibits the migration of NCI-H1299 cells in a concentration-dependent manner^[1].
WC-27 (0.625-1.25 μM; 10 days) inhibits colony formation of NCI-H1299 cells in a concentration-dependent manner^[1].

Anti-cancer

Cell Cycle Regulation

WC-27 (0.625-5.0 μM; 72 h) induces S-phase arrest in NCI-H1299 cells in a concentration-dependent manner^[1].

Cell Cycle Regulation

WC-27 is a potent Wee1 inhibitor with an IC₅₀ of 2.11 nM^[1] in the cell-free Wee1 enzymatic assay.
WC-27 potently inhibits Wee1 in a 100-kinase panel (97.22% inhibition at 500 nM), while showing weak inhibition of PLK1 and several cell cycle kinases^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis^[1]

Cell Line:

NCI-H1299 cells
Concentration:

0.625, 1.25, 2.5, and 5.0 µM
Incubation Time:

72 h
Result:

S-phase cells: 15.24% at 0.625 µM.
S-phase cells: 21.39% at 1.25 µM.
S-phase cells: 31.39% at 2.5 µM.
S-phase cells: 51.93% at 5.0 µM.

Cell Migration Assay ^[1]

Cell Line:

NCI-H1299 cells
Concentration:

0.625-5.0 µM
Incubation Time:

24 h
Result:

Significantly inhibited wound closure of NCI-H1299 cells in a concentration-dependent manner.
Wound healing rate markedly decreased as concentration increased from 0.625 µM to 5.0 µM.

Cell Proliferation Assay^[1]

Cell Line:

NCI-H1299 cells
Concentration:

0.625 and 1.25 µM
Incubation Time:

10 days
Result:

Colony formation rates decreased significantly.
Near-complete inhibition of colony formation was observed at 0.625 µM.
Almost no colonies formed at 1.25 µM.

Related Protocols :

Parmacokinetics

Species	Dose	Route	AUC_0-t	T_1/2	Clearance (CL)	MRT_0-last	V_dss	C_max	T_max	F
Rat^[1]	10 mg/kg	i.g.	2370 ng·h/mL	3.13 h	/	6.05 h	/	208 ng/mL	4.00 h	49.5 %
Rat^[1]	1 mg/kg	i.v.	412 ng·h/mL	3.07 h	35.2 mL/min/kg	2.35 h	7.93 L/kg	/	/	/

Chemical Information

CAS No. 3069940-08-2
분자량 490.39
화학식 C₂₂H₂₅Cl₂N₇O₂
SMILES

O=C(NC1=C(Cl)C=CC=C1Cl)C2=CN=C(NC3=CN(C4CCN(C)CC4)N=C3)N=C2OCC
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Chen F, et al. Design, synthesis, and biological evaluation of 2-aminopyrimidine-5-carboxamide derivatives as potent selective Wee1 inhibitors. European journal of medicinal chemistry. 2026 Oct 07;321(Pt 2):119402.

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기

Amount: USD 0.00

Biological Activity
- 제품 설명
- IC₅₀ & Target
- In Vitro
Chemical Information
순도&문서
References

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

WC-27

All Wee1 Isoforms

All CDK Isoforms